assay Optimul bleeding as a high-throughput screening option: use of 96-well Characterization of multiple platelet activation pathways in patients with
暂无分享,去创建一个
S. Mundell | S. Watson | T. Warner | A. Mumford | D. Bem | M. Daly | Matthew L. Jones | N. Kirkby | G. Lowe | M. Chan | V. Leo | S. Nisar | V. Morgan | M. Lundberg | Vincenzo C. Leo